← Leaderboards
John C He
James J Peters Va Medical Center
$22,416,030
Attributed
$37,456,691
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,619,900 · 15
VA$0 · 3
By mechanism
R01$33,457,112 · 11
P01$11,064,590 · 2
T32$1,457,973 · 1
K08$640,225 · 1
I01$0 · 3
Top collaborators
- Kyung W Lee10 shared
- Avi Ma'Ayan9 shared
- Sandeep K Mallipattu7 shared
- James C Hone5 shared
- Srinivas Ravi V Iyengar5 shared
- Paul Evan Klotman5 shared
- Ruijie Liu5 shared
- Leslie M Loew5 shared
Most similar at James J Peters Va Medical Center
Same institution · by research overlap
- Christopher P Cardozo$1,203,045
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyMediatingKidney DiseasesInjuryIn VitroEnd Stage Renal FailurePathway InteractionsPodocyteGenesMouse ModelRegulationProteinsChronic Kidney FailureCellsAttenuatedIn VivoApoptosisGene ExpressionMolecularAnimal ModelDisease ProgressionInflammationBasePathogenesis
Grant awards (102)
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV$841,127
R01 · FY2025 · DK · contact PI
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$733,538
R01 · FY2025 · DK
KLF2 is a novel endoprotective target for DKD$721,246
R01 · FY2025 · DK · contact PI
Protective role of CH25h/25-HC in diabetic kidney disease.$0
I01 · FY2025 · VA · contact PI
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV$807,482
R01 · FY2024 · DK · contact PI
KLF2 is a novel endoprotective target for DKD$740,566
R01 · FY2024 · DK · contact PI
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$710,734
R01 · FY2024 · DK
PP2A as a drug target for diabetic kidney disease$565,908
R01 · FY2024 · DK · contact PI
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$488,558
R01 · FY2024 · DK
Role of RARRES1 in diabetic kidney disease$429,081
R01 · FY2024 · DK
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$73,492
R01 · FY2024 · DK
Lead optimization of Tyro3 agonists as a novel therapy for glomerular disease$0
I01 · FY2024 · VA · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2024 · VA · contact PI
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV$841,127
R01 · FY2023 · DK · contact PI
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$740,348
R01 · FY2023 · DK
PP2A as a drug target for diabetic kidney disease$589,487
R01 · FY2023 · DK · contact PI
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$508,915
R01 · FY2023 · DK
Role of RTN1A in the Progression of Diabetic Nephropathy$451,535
R01 · FY2023 · DK · contact PI
Role of RARRES1 in diabetic kidney disease$446,958
R01 · FY2023 · DK
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$73,492
R01 · FY2023 · DK
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2023 · VA · contact PI
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV$858,575
R01 · FY2022 · DK · contact PI
The role of Vpr-mediated cell cycle dysregulation in HIV-associated kidney disease$779,195
R01 · FY2022 · DK
PP2A as a drug target for diabetic kidney disease$589,487
R01 · FY2022 · DK · contact PI
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$508,915
R01 · FY2022 · DK
Role of RTN1A in the Progression of Diabetic Nephropathy$451,535
R01 · FY2022 · DK · contact PI
Role of RARRES1 in diabetic kidney disease$446,958
R01 · FY2022 · DK
Mount Sinai Nephrology Research Training Grant$160,652
T32 · FY2022 · DK · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2022 · VA · contact PI
Long-term consequences of HIV in the Kidney$1,832,641
P01 · FY2021 · DK
PP2A as a drug target for diabetic kidney disease$589,487
R01 · FY2021 · DK · contact PI
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$513,063
R01 · FY2021 · DK
Role of RTN1A in the Progression of Diabetic Nephropathy$451,535
R01 · FY2021 · DK · contact PI
Role of RARRES1 in diabetic kidney disease$447,619
R01 · FY2021 · DK
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)$410,888
P01 · FY2021 · DK · contact PI
Mount Sinai Nephrology Research Training Grant$265,796
T32 · FY2021 · DK · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2021 · VA · contact PI
Long-term consequences of HIV in the Kidney$1,832,641
P01 · FY2020 · DK
PP2A as a drug target for diabetic kidney disease$589,487
R01 · FY2020 · DK · contact PI
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies$561,924
R01 · FY2020 · DK
Role of RTN1A in the Progression of Diabetic Nephropathy$468,910
R01 · FY2020 · DK · contact PI
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)$422,341
P01 · FY2020 · DK · contact PI
Mount Sinai Nephrology Research Training Grant$246,961
T32 · FY2020 · DK · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2020 · VA · contact PI
Long-term consequences of HIV in the Kidney$1,832,644
P01 · FY2019 · DK
Role of HIPK2 in kidney fibrosis$440,204
R01 · FY2019 · DK · contact PI
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)$413,360
P01 · FY2019 · DK · contact PI
Role of RTN1A in the Progression of Diabetic Nephropathy$381,375
R01 · FY2019 · DK · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2019 · VA · contact PI
Long-term consequences of HIV in the Kidney$1,832,642
P01 · FY2018 · DK
Role of HIPK2 in kidney fibrosis$440,204
R01 · FY2018 · DK · contact PI
Cellular and molecular mechanisms of retinoids in podocytes$433,687
R01 · FY2018 · DK · contact PI
Role of RTN1A in the Progression of Diabetic Nephropathy$381,375
R01 · FY2018 · DK · contact PI
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)$347,554
P01 · FY2018 · DK · contact PI
Molecular Basis of Renal Diseases$157,152
T32 · FY2018 · DK · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2018 · VA · contact PI
Long-term consequences of HIV in the Kidney$1,832,641
P01 · FY2017 · DK
Role of HIPK2 in kidney fibrosis$440,204
R01 · FY2017 · DK · contact PI
Cellular and molecular mechanisms of retinoids in podocytes$433,687
R01 · FY2017 · DK · contact PI
Role of RTN1A in the Progression of Diabetic Nephropathy$381,375
R01 · FY2017 · DK · contact PI
Effect of Chronic HIV Infection on Progression of Kidney Disease (MSSM)$307,238
P01 · FY2017 · DK · contact PI
Molecular Basis of Renal Diseases$152,153
T32 · FY2017 · DK · contact PI
Molecular Basis of Renal Diseases$29,782
T32 · FY2017 · DK · contact PI
Role of Protein S in early Diabetic Kidney Disease$0
I01 · FY2017 · VA · contact PI
Role of HIPK2 in kidney fibrosis$440,204
R01 · FY2016 · DK · contact PI
Cellular and molecular mechanisms of retinoids in podocytes$433,687
R01 · FY2016 · DK · contact PI
Role of RTN1A in the Progression of Diabetic Nephropathy$381,375
R01 · FY2016 · DK · contact PI
Molecular Basis of Renal Diseases$152,270
T32 · FY2016 · DK · contact PI
Role of Protein Acetylation in Diabetic kidney Disease$0
I01 · FY2016 · VA · contact PI
Role of HIPK2 in kidney fibrosis$457,579
R01 · FY2015 · DK · contact PI
Cellular and molecular mechanisms of retinoids in podocytes$433,687
R01 · FY2015 · DK · contact PI
Molecular Basis of Renal Diseases$147,939
T32 · FY2015 · DK · contact PI
Role of Protein Acetylation in Diabetic kidney Disease$0
I01 · FY2015 · VA · contact PI
Effects of Glycoxidative Stress on Human Aging$567,026
R01 · FY2014 · DK · contact PI
Cellular and molecular mechanisms of retinoids in podocytes$468,437
R01 · FY2014 · DK · contact PI
Role of HIPK2 in Kidney Tubulointerstitial Injury$345,340
R01 · FY2014 · DK · contact PI
Molecular Basis of Renal Diseases$145,268
T32 · FY2014 · DK · contact PI
Role of Protein Acetylation in Diabetic kidney Disease$0
I01 · FY2014 · VA · contact PI
Dynamics Underlying Tissue Integrity$1,291,275
R01 · FY2013 · DK
Role of HIPK2 in Kidney Tubulointerstitial Injury$333,253
R01 · FY2013 · DK · contact PI
Role of Protein Acetylation in Diabetic kidney Disease$0
I01 · FY2013 · VA · contact PI
Dynamics Underlying Tissue Integrity$1,353,508
R01 · FY2012 · DK
Role of HIPK2 in Kidney Tubulointerstitial Injury$345,340
R01 · FY2012 · DK · contact PI
AGE and podocyte injury in diabetic nephropathy$0
I01 · FY2012 · VA · contact PI
Dynamics Underlying Tissue Integrity$1,331,213
R01 · FY2011 · DK
Role of HIPK2 in Kidney Tubulointerstitial Injury$345,340
R01 · FY2011 · DK · contact PI
Cellular and molecular mechanism of retinoids in podocytes$284,907
R01 · FY2011 · DK · contact PI
AGE and podocyte injury in diabetic nephropathy$0
I01 · FY2011 · VA · contact PI
Dynamics Underlying Tissue Integrity$1,349,076
R01 · FY2010 · DK
Role of HIPK2 in Kidney Tubulointerstitial Injury$413,325
R01 · FY2010 · DK · contact PI
Cellular and molecular mechanism of retinoids in podocytes$287,786
R01 · FY2010 · DK · contact PI
Dynamics Underlying Tissue Integrity$1,368,491
R01 · FY2009 · DK
Cellular and molecular mechanism of retinoids in podocytes$290,693
R01 · FY2009 · DK · contact PI
Cellular and molecular mechanism of retinoids in podocytes$1,695
R01 · FY2009 · DK · contact PI
AGE and podocyte injury in diabetic nephropathy$0
I01 · FY2009 · VA · contact PI
Cellular and molecular mechanism of retinoids in podocytes$290,693
R01 · FY2008 · DK · contact PI
Cellular and molecular mechanism of retinoids in podocytes$290,787
R01 · FY2007 · DK · contact PI
Pathogenesis of HIVAN: the role of Nef$127,845
K08 · FY2007 · DK · contact PI
Pathogenesis of HIVAN: the role of Nef$128,845
K08 · FY2006 · DK · contact PI
Pathogenesis of HIVAN: the role of Nef$127,845
K08 · FY2005 · DK
Pathogenesis of HIVAN: the role of Nef$127,845
K08 · FY2004 · DK
Pathogenesis of HIVAN: the role of Nef$127,845
K08 · FY2003 · DK